Proteomic shifts post plasma cell therapy in AL amyloid plaques and potential implications for light chain directed anti-fibril monoclonal antibodies

Proteomic shifts post plasma cell therapy in AL amyloid plaques and potential implications for light chain directed anti-fibril monoclonal antibodies

Not available.

Saved in:

Bibliographic Details
Main Authors:	Matthew J. Rees, Surendra Dasari, Ellen D. McPhail, Angela Dispenzieri, Cristine M. Charlesworth, Eli Muchtar, Morie Gertz, Navin Gupta, Emilie Anderson, Samantha N. Quang, Christopher Dick, Shaji Kumar, Taxiarchis Kourelis
Format:	Article
Language:	English
Published:	Ferrata Storti Foundation 2025-07-01
Series:	Haematologica
Online Access:	https://haematologica.org/article/view/12192
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Value of serum-free light chain measurements in response and progression assessment in multiple myeloma with monoclonal protein measurable by electrophoresis
by: Elham Askari, et al.
Published: (2025-08-01)

Clonal plasma cell features in light-chain amyloidosis are associated with depth and timing of cardiac response independent of hematologic response
by: Matthew J. Rees, et al.
Published: (2025-05-01)

From CyBorD to dara-CyBorD, ASCT utilization trends in AL amyloidosis: a 15-year analysis
by: Eli Muchtar, et al.
Published: (2025-08-01)

On the Therapeutic Use of Monoclonal Antibodies Against Amyloid Plaques in Older Adults with Down Syndrome: A Narrative Review and Perspective
by: Alberto C. S. Costa
Published: (2024-10-01)

Predictors of mortality by an artificial intelligence enhanced electrocardiogram model for cardiac amyloidosis
by: Jennifer M. Amadio, et al.
Published: (2025-02-01)

Anti-Amyloid Imaging Abnormality in the Era of Anti-Amyloid Beta Monoclonal Antibodies: Recent Updates for the Radiologist
by: So Yeong Jeong, et al.
Published: (2025-01-01)

Mechanotransduction Activates Microglia and Impairs Phagocytosis in Stiff Amyloid‐β Plaques
by: Yulin Liu, et al.
Published: (2025-08-01)

RNA aptamer probes as optical imaging agents for the detection of amyloid plaques.
by: Christian T Farrar, et al.
Published: (2014-01-01)

The ventilator and the vaccine: Necropolitics and fat in the Covid-19 pandemic
by: Deborah McPhail
Published: (2024-03-01)

Anti-amyloid Monoclonal Antibodies for Alzheimer’s Disease: A New Hope? (Review)
by: I. A. Mazerkina
Published: (2025-04-01)

Amyloid-Related Imaging Abnormalities in Anti-Amyloid Monoclonal Antibody Therapy for Alzheimer’s Disease: Expert Recommendation for Standard MRI Protocol
by: Jimin Kim, et al.
Published: (2025-01-01)

Conceptual Progression in Innovative Learning Spaces
by: Graham John McPhail
Published: (2015-12-01)

Specific associations between plasma biomarkers and postmortem amyloid plaque and tau tangle loads
by: Gemma Salvadó, et al.
Published: (2023-03-01)

Unraveling the complex role of microglia in Alzheimer’s disease: amyloid β metabolism and plaque formation
by: Sho Takatori, et al.
Published: (2025-05-01)

The Efficacy of Anti-amyloid Monoclonal Antibodies in Early Alzheimer’s Dementia: A Systematic Review
by: Alyaa Mostafa, et al.
Published: (2025-05-01)

Strategy for gene expression-based biomarker discovery
by: Joseph Monforte, et al.
Published: (2005-04-01)

A reduced astrocyte response to β-amyloid plaques in the ageing brain associates with cognitive impairment.
by: Ryan Mathur, et al.
Published: (2015-01-01)

Homeostatic microglia initially seed and activated microglia later reshape amyloid plaques in Alzheimer’s Disease
by: Nóra Baligács, et al.
Published: (2024-12-01)

Advancements in Alzheimer's Disease Therapy: The Role of Anti-Amyloid Monoclonal Antibodies - A Literature Review
by: Agnieszka Skoczeń, et al.
Published: (2025-03-01)

Passive Anti-amyloid Beta Monoclonal Antibodies: Lessons Learned over Past 20 Years
by: Alexandra Wicker, et al.
Published: (2024-10-01)

Second-generation anti-amyloid monoclonal antibodies for Alzheimer’s disease: current landscape and future perspectives
by: Byeong-Hyeon Kim, et al.
Published: (2025-01-01)

Monoclonal antibodies against beta-amyloid protein (lecanemab and donanemab) should not be used in the treatment of Alzheimer's disease
by: Ricardo Nitrini, et al.
Published: (2025-05-01)

Managing Time for Heads of Music Departments
by: Graham John McPhail, et al.
Published: (2018-08-01)

Venetoclax-based treatment combinations in relapsed/refractory multiple myeloma: practice patterns and impact of secondary cytogenetic abnormalities on outcomes
by: Abiola Bolarinwa, et al.
Published: (2025-04-01)

Exploring math-identities of successful young women in post-compulsory mathematics
by: Emilie Gertz
Published: (2024-11-01)

PLD3 is a neuronal lysosomal phospholipase D associated with β-amyloid plaques and cognitive function in Alzheimer's disease.
by: Alex G Nackenoff, et al.
Published: (2021-04-01)

Co-Localized in Amyloid Plaques Cathepsin B as a Source of Peptide Analogs Potential Drug Candidates for Alzheimer’s Disease
by: Marilena K. Theodoropoulou, et al.
Published: (2024-12-01)

Standardization of criteria in MacCAT‐T and MacCAT‐CR for monoclonal anti–beta‐amyloid antibodies: A Delphi study
by: Jonas Karneboge, et al.
Published: (2025-04-01)

The novel role of Kallistatin in linking metabolic syndromes and cognitive memory deterioration by inducing amyloid-β plaques accumulation and tau protein hyperphosphorylation
by: Weiwei Qi, et al.
Published: (2025-08-01)

Protein co-aggregates of dense core amyloid plaques and CSF differ in rapidly progressive Alzheimer’s disease and slower sporadic Alzheimer’s disease
by: Gurkan Bebek, et al.
Published: (2025-05-01)

Recent advances in proteomic analysis to study carotid artery plaques
by: Gabriel Cruz-González, MD, et al.
Published: (2024-01-01)

Elevation of ganglioside degradation pathway drives GM2 and GM3 within amyloid plaques in a transgenic mouse model of Alzheimer's disease
by: Wenxuan Wang, et al.
Published: (2025-02-01)

Correction: Fluorescent indolizine derivative YI-13 detects amyloid-β monomers, dimers, and plaques in the brain of 5XFAD Alzheimer transgenic mouse model.
by: DaWon Kim, et al.
Published: (2021-01-01)

Solving the Amyloid Paradox: Unveiling the Complex Pathogenicity of Amyloid Fibrils
by: Maksim I. Sulatsky, et al.
Published: (2025-07-01)

Prion seeding activities of mouse scrapie strains with divergent PrPSc protease sensitivities and amyloid plaque content using RT-QuIC and eQuIC.
by: Sarah Vascellari, et al.
Published: (2012-01-01)

An Electronic Medical Record–Based Prognostic Model for Inpatient Falls: Development and Internal-External Cross-Validation
by: Rex Parsons, et al.
Published: (2024-11-01)

The Australian clinical trial landscape: Perceptions of rural, regional and remote health service capacity and capability
by: Jenna Graffini, et al.
Published: (2024-12-01)

Innovative Power Generation System for Large Ships Based on Fuel Cells: A Technical–Economic Comparison with a Traditional System
by: Alessandro Ruvio, et al.
Published: (2025-03-01)

Retinal amyloid angiopathy
by: Alex Tiburtino Meira, et al.
Published: (2021-11-01)

Amyloid tumor of the breast
by: Makiko Mori, et al.
Published: (2019-02-01)